NCT04028869View on ClinicalTrials.gov

Clinical Observation of Long-term Efficacy and Safety of Glycyrrhizic Acid Preparation in the Therapy of Autoimmune Liver Disease

CompletedOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

March 30, 2019

Study Completion Date

March 30, 2019

Conditions
Autoimmune Liver Disease
Interventions
DRUG

Glycyrrhizic acid preparation

To analyze the clinical effect of glycyrrhizic acid preparation for autoimmune liver disease for 144 weeks and the safety during treatment

Trial Locations (1)

100015

liver disease center, Beijing Ditan Hospital, Beijing

All Listed Sponsors
lead

Beijing Ditan Hospital

OTHER

NCT04028869 - Clinical Observation of Long-term Efficacy and Safety of Glycyrrhizic Acid Preparation in the Therapy of Autoimmune Liver Disease | Biotech Hunter | Biotech Hunter